RADP / Pulse Nigeria > News > Local

First prevention drug for high-risk groups approved in EU

Gbenga Bada

July 22, 2016 11:14 PM

The London-based agency said that PrEP was recommended by the World Health Organisation (WHO).

Diabetes cases reach 422 million as poorer countries see steep rises

The first drug designed to help to prevent HIV transmission in people at high risk of infection has been approved for use in the European Union on Friday.

Recommended articles

The European Medicines Agency (EMA) approved the use of the drug Truvada for pre-exposure prophylaxis, or PrEP, in combination with safer sex practices.

``The drug will help people who do not have HIV but who are at high risk of infection with HIV to lower their chances of becoming infected when they are exposed to the virus.

``The oral drug should be used in combination with condoms as part of an HIV prevention strategy.

``Truvada was previously approved for use in the EU as part of drug cocktails designed to treat people infected with HIV,’’ the WHO said.

The WHO estimates that some 36.7 million people worldwide were living with HIV at the end of 2015.

Gbenga Bada

Enhance Your Pulse News Experience!

Get rewards worth up to $20 when selected to participate in our exclusive focus group. Your input will help us to make informed decisions that align with your needs and preferences.

I've got feedback!